Qualitative vs. quantitative atopic dermatitis criteria - In historical and present perspectives

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 4, 2016, Pages 604-618

  Andersen, R M ^a,b   Thyssen, J P ^b   Maibach, H I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FILAGGRIN; THYMIC STROMAL LYMPHOPOIETIN;

ATOPIC DERMATITIS; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE MUTATION; HERITABILITY; HUMAN; HYPERSENSITIVITY; LABORATORY TEST; PRIORITY JOURNAL; PRURITUS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; SKIN SENSITIZATION; DERMATITIS, ATOPIC; FEMALE; HISTORY; MALE; PATHOPHYSIOLOGY;

DERMATITIS, ATOPIC; FEMALE; HISTORY, 20TH CENTURY; HUMANS; MALE;

EID: 84962069935     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13442     Document Type: Review

References (121)

1. Deckers I, McLean S, Linssen S, Mommers M, van Schayck C, Sheikh A,. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One 2012; 7: e39803.
2. Palmer C, Irvine A, Terron-Kwiatkowski A, et al,. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
3. Barker J, Palmer C, Zhao Y, et al,. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007; 127: 564-567.
4. Carson CG, Rasmussen MA, Thyssen JP, Menné T, Bisgaard H,. Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS One 2012; 7: e48678.
5. Simpson EL, Keck LE, Chalmers JR, Williams HC,. How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies. J Allergy Clin Immunol 2012; 130: 137-144.
6. Hanifin J, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92 (Suppl): 44-47.
7. Coca AAF, Cooke RAR,. On the classification of the phenomena of hypersensitiveness. J Immunol 1923; 8: 163-182.
8. Doerr R,. Kolle-Wassermann-Handbuch Der Pathogenen Mikroorganismen, 2te Auflage. Gustav Fischer, Jena, Germany, 1914.
9. Coca A, Grove E,. Studies in hypersensitiveness XIII. A study of the atopic reagins. J Immunol 1925; 10: 445-464.
10. Cooke R, Vander Veer A,. Human sensitization. J Immunol 1916; 1: 201-305.
11. Mier P,. Earliest description of the atopic syndrome? Br J Dermatol 1974; 92: 359.
12. Wallach D, Taïeb A,. Atopic dermatitis/atopic eczema. Chem Immunol Allergy 2014; 100: 81-96.
13. Bateman T,. Delineations of Cutaneous Diseases Comprised in the Classification of Dr. Willan, 4th edn. Longman, London, 1817.
14. Wilson E,. Lectures on Eczema and Eczematous Affections: With an Introduction on the General Pathology of the Skin and an Appendix of Essays and Cases. Churchill, London, 1870.
15. Besnier E,. Première note et observations préliminaires pour servir d'introduction à l'étude des prurigos diathésiques (dermatitis multiformes prurigineuses chroniques exacerbantes et paroxystiques, du type du prurigo de Hebra). Ann Dermatol Syph 1892; 3: 634-648.
16. Wise F, Sulzberger M, eds. The 1933 Year Book of Dermatology and Syphilology. The Year Book Publishers, Chicago, 1933.
17. Hill L, Sulzberger M,. Evolution of atopic dermatitis. Arch Derm Syphilol 1935; 32: 451-463.
18. Sulzberger M, Sauer G, Herrmann F,. Effects of ACTH and cortisone on certain sideases and physiologic functions of the skin: I. Effects of ACTH. J Invest Dermat 1951; 16: 323-338.
19. Szentivanyi A,. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968; 42: 203-232.
20. Faulstich M, Williamson D,. An overview of atopic dermatitis: toward a bio-behavioural integration. J Psychosom Res 1985; 29: 647-654.
21. Wollenberg A, Bieber T,. Atopic dermatitis: from the genes to skin lesions. Allergy 2000; 55: 205-213.
22. De la Cuesta CG, Sanz ML, Gamboa PM, Diéguez I, Oehling A,. Modulation of beta 2-adrenoceptors in lymphocytes of allergic patients after in vitro antigenic stimulation. J Investig Allergol Clin Immunol 1993; 3: 130-135.
23. Ishizaka K, Ishizaka T, Hornbrook MM,. Physicochemical properties of reaginic antibody V. Correlation of reaginic activity with γ E-globulin antibody. J Immunol 1966; 97: 840-853.
24. Juhlin L,. Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria. Arch Dermatol 1969; 100: 12-16.
25. Thyssen JP, Kezic S,. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 2014; 134: 792-799.
26. Rajka G,. Diagnosis of atopic dermatitis. In, Rajka G, ed. Atopic Dermatitis. W.B. Saunders Ltd, London, 1975: 141.
27. Schultz LarsenF, Diepgen TL, Svensson A,. Clinical criteria in diagnosting AD The Lillehammer criteria 1994. Acta Derm Venereol Suppl (Stockh) 1996; 196: 115-119.
28. Hanifin J, Lobitz W,. Newer concepts of atopic dermatitis. Arch Dermatol 1977; 113: 663-670.
29. Tagami H,. Japanese dermatology association criteria for the diagnosis of atopic dermatitis. J Dermatol 1995; 22: 966-967.
30. Asher MI, Keil U, Anderson HR, et al,. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
31. Bos JD, Van Leent EJ, Sillevis Smitt JH,. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998; 7: 132-138.
32. Kang K, Tian R,. Atopic dermatitis-an evaluation of clinical and laboratory findings. Int J Dermatol 1987; 26: 27-32.
33. Williams HC, Burney PGJ, Hay RJ, et al,. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131: 383-396.
34. Diepgen TL, Sauerbrei W, Fartasch M,. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996; 49: 1031-1038.
35. Jøhnke H, Vach W, Norberg LA, Bindslev-Jensen C, Høst A, Andersen KE,. A comparison between criteria for diagnosing atopic eczema in infants. Br J Dermatol 2005; 153: 352-358.
36. Dubin D,. Citation classics in clinical dermatologic journals. Arch Dermatol 1993; 129: 1121.
37. Williams H, Burney PGJ, Pembroke AC, Hay RJ,. The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131: 406-416.
38. De D, Kanwar AJ, Handa S,. Comparative efficacy of Hanifin and Rajka's criteria and the UK working party's diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North India. J Eur Acad Dermatol Venereol 2006; 20: 853-859.
39. Williams HC, Burney PG, Strachan D, Hay RJ,. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994; 131: 397-405.
40. Brenninkmeijer EEA, Schram ME, Leeflang MMG, Bos JD, Spuls PI,. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008; 158: 754-765.
41. http://isaac.auckland.ac.nz/phases/phaseone/phaseonemanual.pdf.
42. Williams H, Robertson C, Stewart A, et al,. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999; 103 (1 Pt 1): 125-138.
43. Haileamlak A, Lewis S, Britton J, et al,. Validation of the International Study of Asthma and Allergies in Children (ISAAC) and U.K. criteria for atopic eczema in Ethiopian children. Br J Dermatol 2005; 152: 735-741.
44. Flohr C, Weinmayr G, Weiland SK, et al,. How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 2009; 161: 846-853.
45. Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R,. A half of schoolchildren with "ISAAC eczema" are ill with allergic contact dermatitis. J Eur Acad Dermatol Venereol 2011; 25: 1104-1107.
46. Apfelbacher CJ, Diepgen TL, Schmitt J,. Determinants of eczema: population-based cross-sectional study in Germany. Allergy 2011; 66: 206-213.
47. Illi S, von Mutius E, Lau S, et al,. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925-931.
48. Böhme M, Svensson A, Kull I, Nordvall SL, Wahlgren CF,. Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study. Acta Derm Venereol 2001; 81: 193-197.
49. Kusel MMH, Holt PG, De Klerk N, Sly PD,. Support for 2 variants of eczema. J Allergy Clin Immunol 2005; 116: 1067-1072.
50. Xiu E, Loo L, Shek P, Hoe O,. Atopic dermatitis in early life: evidence for at least three phenotypes? Results from the GUSTO study. Int Arch Allergy Immunol 2015; 116: 273-279.
51. Lötvall J, Akdis CA, Bacharier LB, et al,. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127: 355-360.
52. Wenzel S,. Severe asthma: from characteristics to phenotypes to endotypes. Clin Exp Allergy 2012; 42: 650-658.
53. Meng L, Wang L, Tang H, et al,. Filaggrin gene mutation c.3321delA is associated with various clinical features of atopic dermatitis in the Chinese Han population. PLoS One 2014; 9: e98235.
54. Rudzki E, Samochocki Z, Rebandel P,. Frequency and significance of the major and minor features of hanifin and Rajka among patients with atopic dermatitis. Dermatology 1994; 189: 41-46.
55. Rupnik H, Rijavec M, Korošec P,. Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood. Br J Dermatol 2015; 172: 455-461.
56. Svensson A, Edman B, Möller H,. A diagnostic tool for atopic dermatitis based on clinical criteria. Acta Derm Venereol Suppl (Stockh) 1985; 114: 33-40.
57. Diepgen TL, Fartasch M, Hornstein OP,. Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population. Acta Derm Venereol Suppl (Stockh) 1989; 144: 50-54.
58. Darsow U, Raap U, Ständer S,. Atopic dermatitis. In, Carstens E, Akiyama T, eds. Itch: Mechanisms and Treatment. CRC Press, Boca Baton, FL, USA, 2014: 19-27.
59. Chrostowska-Plak D, Salomon J, Reich A, Szepietowski JC,. Clinical aspects of itch in adult atopic dermatitis patients. Acta Derm Venereol 2009; 89: 379-383.
60. Chrostowska-Plak D, Reich A, Szepietowski JC,. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2013; 27: e239-e242.
61. Wahlgren CF,. Measurement of itch. Semin Dermatol 1995; 14: 277-284.
62. Noro Y, Omoto Y, Umeda K, et al,. Novel acoustic evaluation system for scratching behavior in itching dermatitis: rapid and accurate analysis for nocturnal scratching of atopic dermatitis patients. J Dermatol 2014; 41: 233-238.
63. Benjamin K, Waterston K, Russell M, Schofield O, Diffey B, Rees J,. The development of an objective method for measurement scratch in children with atopic dermatitis suitable for clinical use. J Am Acad Dermatol 2004; 50: 33-40.
64. Murray CS, Rees JL,. Are subjective accounts of itch to be relied on? The lack of relation between visual analogue itch scores and actigraphic measures of scratch. Acta Derm Venereol 2011; 91: 18-23.
65. Furue M, Ebata T, Ikoma A, et al,. Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Derm Venereol 2013; 93: 214-215.
66. Darsow U, Scharein E, Simon D, Walter G, Bromm B, Ring J,. New aspects of itch pathophysiology: component analysis of atopic itch using the "Eppendorf Itch Questionnaire". Int Arch Allergy Immunol 2001; 124: 326-331.
67. Melzack R,. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-299.
68. Pfab F, Valet M, Sprenger T, et al,. Temperature modulated histamine-itch in lesional and nonlesional skin in atopic eczema-a combined psychophysical and neuroimaging study. Allergy 2010; 65: 84-94.
69. Diepgen TL, Fartasch M,. Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992; 176: 13-18.
70. Böhme M, Svensson a, Kull I, Wahlgren CF,. Hanifin's and Rajka's minor criteria for atopic dermatitis: which do 2-year-olds exhibit? J Am Acad Dermatol 2000; 43 (5 Pt 1): 785-792.
71. Nagaraja S, Kanwar A, Dhar S, Singh S,. Frequency and significance of minor clinical features in various age-related subgroups of atopic dermatitis in children. Pediatr Dermatol 1996; 13: 13-16.
72. Werner Y, Lindberg M,. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985; 65: 102-105.
73. Tagami H, Kobayashi H, O'goshi K, Kikuchi K,. Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products. J Cosmet Dermatol 2006; 5: 140-149.
74. Horii I, Nakayama Y, Obata M, Tagami H,. Stratum corneum hydration and amino acid content in xerotic skin. Br J Dermatol 1989; 121: 587-592.
75. Mischo M, von Kobyletzki LB, Bründermann E, et al,. Similar appearance, different mechanisms: xerosis in HIV, atopic dermatitis and ageing. Exp Dermatol 2014; 23: 446-448.
76. Howell MD, Kim BE, Gao P, et al,. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2009; 124 (3 Suppl 2): R7-R12.
77. O'Regan GM, Kemperman PMJH, Sandilands A, et al,. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol 2010; 126: 574-580.e1
78. Kezic S, Kammeyer A, Calkoen F, Fluhr JW, Bos JD,. Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br J Dermatol 2009; 161: 1098-1104.
79. Brenninkmeijer EEA, Spuls PI, Legierse CM, Lindeboom R, Smitt JHS, Bos JD,. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol 2008; 58: 407-414.
80. Deleuran M, Vestergaard C,. Clinical heterogeneity and differential diagnosis of atopic dermatitis. Br J Dermatol 2014; 170 (Supplement S1): 1-5.
81. Williams HC, Strachan DP,. The natural history of childhood eczema: observations from the British 1958 birth cohort study. Br J Dermatol 1998; 139: 834-839.
82. Ziyab aH, Raza A, Karmaus W, et al,. Trends in eczema in the first 18 years of life: results from the Isle of Wight 1989 birth cohort study. Clin Exp Allergy 2010; 40: 1776-1784.
83. Garmhausen D, Hagemann T, Bieber T, et al,. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 2013; 68: 498-506.
84. Rystedt I,. Long term follow-up in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1986; 114: 117-120.
85. Wüthrich B,. Epidemiology and naturel history of atopic dermatitis. Allergy Clin Immunol Int 1996; 8: 77-82.
86. Lammintausta K, Kalimo K, Raitala R, Forsten Y,. Prognosis of atopic dermatitis. Int J Dermatol 1991; 30: 563-568.
87. Halkjaer LB, Loland L, Buchvald FF, et al,. Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children. Arch Dermatol 2006; 142: 561-566.
88. Landeck L, Visser M, Kezic S, John SM,. Genotype-phenotype associations in filaggrin loss-of-function mutation carriers. Contact Dermatitis 2013; 68: 149-155.
89. Lubs M-LE,. Emperic risks for genetic counseling in families with allergy. J Pediatr 1972; 80: 26-31.
90. Schultz Larsen F, Holm N V, Henningsen K,. Atopic dermatitis A genetic-epideomiologic study in a population-based twin sample. J Am Acad Dermatol 1986; 15: 487-494.
91. Thomsen SF, Ulrik CS, Kyvik KO, et al,. Importance of genetic factors in the etiology of atopic dermatitis: a twin study. Allergy Asthma Proc 2007; 28: 535-539.
92. Bradley M, Kockum I, Söderhäll C, et al,. Characterization by phenotype of families with atopic dermatitis. Acta Derm Venereol 2000; 80: 106-110.
93. Bisgaard H, Halkjaer LB, Hinge R, et al,. Risk analysis of early childhood eczema. J Allergy Clin Immunol 2009; 123: 1355-1360.e5.
94. Wen H-J, Chen P-C, Chiang T-L, Lin S-J, Chuang Y-L, Guo Y-L,. Predicting risk for early infantile atopic dermatitis by hereditary and environmental factors. Br J Dermatol 2009; 161: 1166-1172.
95. Schmitz R, Atzpodien K, Schlaud M,. Prevalence and risk factors of atopic diseases in German children and adolescents. Pediatr Allergy Immunol 2012; 23: 716-723.
96. Purvis D, Thompson J, Clark P, et al,. Risk factors for atopic dermatitis in New Zealand children at 3,5 years of age. Br J Dermatol 2005; 152: 742-749.
97. Vestergaard C, Deleuran M,. Advances in the diagnosis and therapeutic management of atopic dermatitis. Drugs 2014; 74: 757-769.
98. Flohr C, Johansson SGO, Wahlgren CF, Williams H,. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004; 114: 150-158.
99. Wakamori T, Katoh N, Hirano S, Kishimoto S, Ozasa K,. Atopic dermatitis, dry skin and serum IgE in children in a community in Japan. Int Arch Allergy Immunol 2009; 149: 103-110.
100. Glatz M, Buchner M, von Bartenwerffer W, et al,. Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. Acta Derm Venereol 2015; 95: 191-196.
101. Stalder J, Taieb A,. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186: 23-31.
102. Kurukulaaratchy RJ, Matthews S, Arshad SH,. Defining childhood atopic phenotypes to investigate the association of atopic sensitization with allergic disease. Allergy 2005; 60: 1280-1286.
103. Simpson A, Tan VYF, Winn J, et al,. Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med 2010; 181: 1200-1206.
104. Brown S, McLean W,. One remarkable molecule: filaggrin. J Invest Dermatol 2012; 132 (3 Pt 2): 751-762.
105. Brown SJ, Asai Y, Cordell HJ, et al,. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 2011; 127: 661-667.
106. Irvine AD, McLean WHI, Leung DYM,. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-1327.
107. Margolis DJ, Kim B, Apter AJ, et al,. Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis. JAMA Dermatol. 2014; 150: 1-6.
108. Gao P-S, Rafaels NM, Mu D, et al,. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 2010; 125: 1403-1407.e4.
109. Sano Y, Masuda K, Tamagawa-Mineoka R, et al,. Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis. Clin Exp Immunol 2013; 171: 330-337.
110. Kyoya M, Kawakami T, Soma Y,. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis. J Dermatol Sci 2014; 75: 204-207.
111. Hijnen D, De Bruin-Weller M, Oosting B, et al,. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004; 113: 334-340.
112. Kou K, Okawa T, Yamaguchi Y, et al,. Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol 2014; 171: 283-291.
113. Oren E, Banerji A, Camargo C,. Vitamin D and atopic disorders in a obese population screened for vitamin D deficiency. J Allergy Clin Immunol 2008; 121: 533-534.
114. Cheng HM, Kim S, Park G-H, et al,. Low vitamin D levels are associated with atopic dermatitis, but not allergic rhinitis, asthma, or IgE sensitization, in the adult Korean population. J Allergy Clin Immunol 2014; 133: 1048-1055.
115. David TJ, Wells FE, Sharpe TC, Gibbs AC,. Low serum zinc in children with atopic eczema. Br J Dermatol 1984; 111: 597-601.
116. Kim JE, Yoo SR, Jeong MG, Ko JY, Ro YS,. Hair zinc levels and the efficacy of oral zinc supplementation in patients with atopic dermatitis. Acta Derm Venereol 2014; 94: 558-562.
117. Kägi M, Joller-Jemelka H, Wüthrich B,. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clininal activity of atopic dermatitis. Dermatology 1992; 185: 88-92.
118. Kumar M, Singh P, Patel P,. Clinico-immunological profile and their correlation with severity of atopic dermatitis in Eastern Indian children. J Nat Sci Biol Med 2014; 5: 95-100.
119. Inoue Y, Aihara M, Kirino M, et al,. Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is associated with Staphylococcus aureus colonization. Br J Dermatol 2011; 164: 560-567.
120. Nobbe S, Dziunycz P, Mühleisen B, et al,. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol 2012; 92: 24-28.
121. Aletaha D, Neogi T, Silman AJ, et al,. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-2581.